|
Herpes zoster
is infection that results when varicella-zoster virus reactivates
from its latent state in a posterior dorsal root ganglion. Symptoms usually
begin with pain along the affected dermatome, followed in 2 to 3
days by a vesicular eruption that is usually diagnostic. Treatment
is antiviral drugs and possibly corticosteroids given within 72
h after skin lesions appear.
Chickenpox and herpes zoster are caused by the varicella-zoster virus (human herpesvirus type 3), chickenpox being the acute invasive phase of the virus (see Herpesviruses: Chickenpox) and herpes zoster (shingles) representing reactivation of the latent phase. Herpes zoster inflames the sensory root ganglia; the skin of the associated dermatome; and sometimes the posterior and anterior horns of the gray matter, meninges, and dorsal and ventral roots. Herpes zoster frequently occurs in elderly and HIV-infected patients and is more severe in immunocompromised patients. There are no clear-cut precipitants.
Symptoms
and Signs
Lancinating, dysesthetic, or other pain develops in the involved site, followed in 2 to 3 days by a rash, usually crops of vesicles on an erythematous base. The site is usually ≥ 1 adjacent dermatomes in the thoracic or lumbar region. Lesions are typically unilateral. The site is usually hyperesthetic, and pain may be severe. Lesions usually continue to form for about 3 to 5 days. Herpes zoster may disseminate to other regions of the skin and to visceral organs, especially in immunocompromised patients.
Fewer than 4% of patients with herpes zoster experience another outbreak. However, many, particularly the elderly, have persistent or recurrent pain in the involved distribution (postherpetic neuralgia), which may persist for months, years, or permanently. Infection in the trigeminal nerve is particularly likely to lead to severe, persistent pain. The pain of postherpetic neuralgia may be sharp and intermittent or constant and may be debilitating.
Geniculate
zoster (Ramsay Hunt syndrome) results from involvement of the geniculate ganglion. Ear pain, facial paralysis, and sometimes vertigo occur. Vesicles erupt in the external auditory canal, and taste may be lost in the anterior 2⁄3 of the tongue (see Inner Ear Disorders: Herpes Zoster Oticus).
Ophthalmic
herpes zoster (see also Corneal Disorders: Herpes Zoster Ophthalmicus) results from involvement of the gasserian ganglion, with pain and vesicular eruption in and around the eye, in the distribution of the ophthalmic division of the 5th cranial nerve. Vesicles on the tip of the nose (Hutchinson's sign) indicate involvement of the nasociliary branch and often severe ocular disease. However, eye involvement may occur in the absence of lesions on the tip of the nose.
Intraoral zoster is uncommon but may produce a sharp unilateral distribution of lesions. No intraoral prodromal symptoms occur.
Diagnosis
Herpes zoster is suspected in patients with the characteristic rash and sometimes in patients with typical pain in a dermatomal distribution. Diagnosis is usually based on the virtually pathognomonic rash. If the diagnosis is equivocal, demonstrating multinucleate giant cells with a Tzanck test can confirm infection with a herpes virus. Herpes simplex virus (HSV) may produce nearly identical lesions, but unlike herpes zoster, HSV tends to recur and is not dermatomal. Viruses can be differentiated by culture. Antigen detection from a biopsy sample can be useful.
Treatment
and Prevention
Wet compresses are soothing, but systemic analgesics are often necessary. Treatment with oral antivirals decreases the severity and duration of the acute eruption, the incidence of postherpetic neuralgia, and the rate of serious complications in immunocompromised patients and pregnant women. Treatment should start as soon as possible, ideally during the prodrome, and is likely ineffective if given > 72 h after skin lesions appear. Famciclovir 500 mg po tid for 7 days and valacyclovir 1 g po tid for 7 days have better bioavailability with oral dosing than acyclovir and therefore are generally preferred to oral acyclovir 800 mg 5 times/day for 7 to 10 days for herpes zoster. Corticosteroids increase the rate of healing and resolution of acute pain moderately but do not decrease the incidence of postherpetic neuralgia.
For immunocompromised patients, acyclovir is recommended at a dosage of 10 mg/kg IV q 8 h for 7 days for adults and 500 mg/m2 IV q 8 h for 7 to 10 days for children ≥ 1 yr.
Prevention involves preventing primary infection (chickenpox) by use of the varicella vaccine (see Herpesviruses: Prevention) in children and susceptible adults. In a large study, use of a more potent vaccine to boost the immune response in elderly patients who previously had chickenpox was recently shown to decrease the incidence of zoster.
Management of postherpetic neuralgia can be particularly difficult. Treatments include gabapentin , cyclic antidepressants, and topical capsaicin or lidocaine ointment. Opioid analgesics may be necessary. Intrathecal methylprednisolone may be of benefit.
For treatment of ophthalmic herpes zoster, an ophthalmologist should be consulted (see Corneal Disorders: Treatment). For treatment of otic herpes zoster, an otolaryngologist should be consulted (see Inner Ear Disorders: Treatment).
Last full review/revision November 2005
Content last modified November 2005
| 
